Fig. 4From: Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell CarcinomaThe overall survival curves based on the combined CDK5 and p21 expression in ccRCC patients. a Different group of Patients in OS analysis. b CLPL group was compared with the other groups. c The OS analysis of patients in CLPL group and CHPL group. d The OS analysis of patients in CLPL group and CLPH groupBack to article page